This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mosher, L. R. Articles by Menn, A. Search for Related Content PubMed PubMed Citation Articles by Mosher, L. R. Articles by Menn, A. Social Bookmarking                         What's this?

The Treatment of Acute Psychosis Without Neuroleptics: Six-Week Psychopathology Outcome Data From the Soteria Project

Soteria Project, 401 Hungerford Drive, Suite 500, Rockville, MD 20850, USA

Robert Vallone

Soteria Project, 2626 Bryant Street, Palo Alto, CA 94306, USA

Alma Menn

Soteria Project, 748 Clipper Street, San Francisco, CA 94114, USA

Background: Today's treatment of acute psychosis usually includes short-term hospitalization and anti-psychotic drug treatment. The Soteria project compared this form of treatment (control) with that of a small, home-like social environment, usually without neuroleptics (experimental).

Method: Newly diagnosed, young, unmarried persons with DSM-11 schizophrenia were randomly assigned to treatment in two experimental and two control settings. Subjects and families were assessed at admission on 29 independent variables. Treatment environments were studied by means of Moos', COPES or WAS scales. Three dependent six week psychopathology outcome measures were collected.

Results: The groups were comparable on 25 of 29 admission variables. The environments of the two experimental and two control settings were different from each other. The milieus were similar to each other within each condition. At six weeks, psychopathology in both groups had improved significantly, and similarly, and overall change was the same.

Conclusion: Specially designed, replicable milieus were able to reduce acute psychotic symptomatology within six weeks, usually without antipsychotic drugs, as effectively as usual hospital ward treatment that included routine neuroleptic drug use.

International Journal of Social Psychiatry, Vol. 41, No. 3, 157-173 (1995)
DOI: 10.1177/002076409504100301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. Lloyd-Evans, M. Slade, D. Jagielska, and S. Johnson Residential alternatives to acute psychiatric hospital admission: systematic review The British Journal of Psychiatry, August 1, 2009; 195(2): 109 - 117. [Abstract] [Full Text] [PDF]

				T. Calton, M. Ferriter, N. Huband, and H. Spandler A Systematic Review of the Soteria Paradigm for the Treatment of People Diagnosed With Schizophrenia Schizophr Bull, January 1, 2008; 34(1): 181 - 192. [Abstract] [Full Text] [PDF]

				J. R Bola Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm? Schizophr Bull, April 1, 2006; 32(2): 288 - 296. [Abstract] [Full Text] [PDF]

				D. Brunt and L. Hansson A Comparison of the Psychosocial Environment of Two Types of Residences for Persons with Severe mental Illness: Small Congregate Community Residences and Psychiatric Inpatient Settings International Journal of Social Psychiatry, December 1, 2002; 48(4): 243 - 252. [Abstract] [PDF]